Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Breast CancerHeart FailureCardiotoxicity
Interventions
DRUG

Carvedilol

50mg/day for 24 weeks. The dose of carvedilol will be up titrate before the dose of 50mg/day

DRUG

Placebo

Placebo similar to the carvedilol up titration but wit no active drug.

Trial Locations (1)

05403-000

Heart Institute University of Sao Paulo, São Paulo

All Listed Sponsors
collaborator

Hospital A.C. Camargo

OTHER

collaborator

Instituto do Cancer do Estado de São Paulo

OTHER

lead

University of Sao Paulo

OTHER

NCT01724450 - Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity | Biotech Hunter | Biotech Hunter